×







We sell 100% Genuine & New Books only!

Chronic Myeloid Neoplasias and Clonal Overlap Syndromes Epidemiology, Pathophysiology and Treatment Options 1st Editon 2010 Hardbound at Meripustak

Chronic Myeloid Neoplasias and Clonal Overlap Syndromes Epidemiology, Pathophysiology and Treatment Options 1st Editon 2010 Hardbound by Richard Greil, Lisa Pleyer, Daniel Neureiter, Viktoria Faber, Springer

Books from same Author: Richard Greil, Lisa Pleyer, Daniel Neureiter, Viktoria Faber

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 24303.00/- [ 15.00% off ]

    Seller Price: ₹ 20658.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Richard Greil, Lisa Pleyer, Daniel Neureiter, Viktoria Faber
    PublisherSpringer
    Edition1st Editon
    ISBN9783211798911
    Pages295
    BindingHardbound
    LanguageEnglish
    Publish YearJune 2010

    Description

    Springer Chronic Myeloid Neoplasias and Clonal Overlap Syndromes Epidemiology, Pathophysiology and Treatment Options 1st Editon 2010 Hardbound by Richard Greil, Lisa Pleyer, Daniel Neureiter, Viktoria Faber

    Introduction The understanding of the genetic, epigenetic, immuno- well as for practicing hematologists or oncologists. logical and biological causes of myeloproliferative dis- Each chapter follows a similar architecture and leads orders has substantially improved in the last few years. through epidemiology, genetic and molecular causes, Together with refined tools in pathology, the successful hematological and clinical findings, prognostic factors establishment of mouse models mimicking at least some and current treatment approaches of the diseases. of the myeloproliferative disorders, and murine models Effort has been made to point out the evolving field of novel drugs in this arena but simultaneously diff- allowing to carefully dissect the role of mutations and gene dosage effects of, for example JAK2, this has led to entiate between standard and experimental treatment ever increasing numbers of modified classification approaches. schemes. It is therefore important for the heamtologist Together with the co-editors and all the authors of or oncologist to keep up with this rapid change in classi- the various chapters I hope that the readers of the book fication language, the upcoming of new entities or differ- will enjoy reading and benefit from the information entiation between, or subclassification of, rare diseases provided. to “Classic” Chronic Myeloproliferative Disorders (CMPDs) — Molecular and Cellular Biology.- Essential Thrombocythemia (ET).- Polycythemia Vera (PV).- Primary Myelofibrosis (PMF) [Previously Chronic Idiopathic Myelofibrosid (CIMF), Myelofibrosis with Myeloid Metaplasia (MMM), Agnogenic Myeloid Metaplasia (AMM)].- Chronic myelogenous leukemia (CML).- Myelodysplastic Syndromes (MDS).- Chronic Myelomonocytic Leukemia (CMML).- Rare Clonal Myeloid Diseases.- De novo “Classic” Paroxysmal Nocturnal Hemoglobinuria (PNH) (Marchiafava-Micheli Syndrome).- Clonal Bone Marrow Failure Overlap Syndromes.



    Book Successfully Added To Your Cart